12 results
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Perioperative Management ... Antirheumatic Medication ... MithuRheum #rheumatology ... #medications #hold ... #autoimmune #pharmacology
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
Measurement in SLE ... 200ng/mL Best indications ... #rheumatology # ... pharmacology #levels ... #lupus #management
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... #pharmacology # ... treatment #medications ... decisionaid #cardiology #hematology
Systemic Lupus Erythematosus - Summary
Antinuclear (ANA) - 95% - Initial screening test
Anti-dsDNA - 50%
 • Associated
• Specific for SLE ... Hydroxychloroquine *Short ... Erythematosus #SLE ... Summary #diagnosis #rheumatology ... #management
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
the Treatment of COVID ... in setting of short ... smfarmhosp_smfh #Drugs #Medications ... #Pharmacology # ... Table #Management
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... other cell types (see ... correlate with severe COVID ... #Pharmacology # ... Management #Medications
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
After non-pharmacologic ... is the newest medication ... than roflumilast (see ... #Pharmacology # ... Dermatology #Management
Rheumatology Guidance - Indications for 3rd Dose (Booster) COVID-19 Vaccines | 8.19.21
Am I eligible for a
Rheumatology Guidance ... Dose (Booster) COVID ... You received 2 shots ... immunocompromised #covid19 ... #vaccination #Rheumatology
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
Non-autoimmune rheumatologic ... Malignancy (e.g. hematologic ... • Malar rash - spares ... activation and/or medications ... Erythematosus #Diagnosis #Rheumatology
Drug Induced Systemic Lupus Erythematosus
> 100 drugs have been associated with drug-induced SLE
High risk (>5%):
 •
with drug-induced SLE ... #DrugInduced #SLE ... Erythematosus #medications ... #drugs #pharmacology ... differential #diagnosis #rheumatology